Background
Methods
Study design
Recruitment and randomization
Blinding
Development of intervention
No | List of questions |
---|---|
1 | What would you like to know during chemotherapy? |
2 | What are the major problems faced before, during and after chemotherapy? |
3 | How do you want us pharmacists to guide or help you during chemotherapy? |
4 | How will our support and guidance be helpful? |
5 | What are the information needed during counselling after chemotherapy? |
Intervention
Instrument
WHO quality of life-BREF (WHOQOL-BREF)
Patient health questionnaire-9 (PHQ-9)
Generalized anxiety disorder-7 (GAD-7)
Sample size estimation
Ethics statement
Statistical analysis
Results
Baseline data
Characteristics | Intervention group | Control group | Total participants | Statistics |
---|---|---|---|---|
n(%) |
n(%) |
n(%) | ||
Age | ||||
Mean, SD | 67.46(1.38) | 63.52(1.43) | 65.49(1.41) |
t = 1.23
p = 0.21 |
Gender | ||||
Male | 34(42.0) | 42(52.5) | 76(47.2) |
χ
2 = 1.78 |
Female | 47(58.0) | 38(47.5) | 85(52.8) |
p = 0.18 |
Race | ||||
Malay | 44(54.3) | 40(50.0) | 84(52.2) |
χ
2 = 0.30 |
Non-Malay | 37(45.7) | 40(50.0) | 77(47.8) |
p = 0.58 |
Religion | ||||
Muslim | 44(54.3) | 40(50.0) | 84(52.2) |
χ
2 = 0.30 |
Non-Muslim | 37(45.7) | 40(50.0) | 77(47.8) |
p = 0.58 |
Marital Status | ||||
Single | 8(9.8) | 3(3.8) | 11(6.8) |
χ
2 = 3.28 |
Married | 54(66.7) | 62(77.5) | 116(72.0) |
p = 0.19 |
Others | 19(23.5) | 15(18.7) | 34(21.1) | |
Education level | ||||
Illiterate | 18(22.2) | 22(27.5) | 40(24.8) |
χ
2 = 0.83 |
Diploma & less | 47(58.0) | 41(51.3) | 88(54.7) |
p = 0.65 |
Degree & above | 16(19.8) | 17(21.2) | 33(20.5) | |
Family history with cancer | ||||
Yes | 42(51.9) | 32(40.0) | 74(46.0) |
χ
2 = 2.27 |
No | 39(48.1) | 48(60.0) | 87(54.0) |
p = 0.13 |
Cancer Stage | ||||
Stage 1 | 7(8.6) | 9(11.2) | 16(9.9) |
χ
2 = 1.03 |
Stage 2 | 16(19.8) | 12(15.0) | 28(17.4) |
p = 0.79 |
Stage 3 | 30(37.0) | 28(35.0) | 58(36.1) | |
Stage 4 | 28(34.6) | 31(38.8) | 59(36.6) |
Change in the quality of life and each domain
Quality of Life | Baseline | 1th follow-up | 2nd follow-up | 3rd follow-up | Effect of intervention | Statistics |
---|---|---|---|---|---|---|
Mean ± SD | Mean differences (95% CI) | |||||
Physical health | ||||||
Intervention Group | 67.23 ± 21.40 | 70.25 ± 19.04 | 73.28 ± 17.08 | 76.17 ± 16.29 | 21.01, (15.75–26.26) | 0.000 |
Control group | 65.30 ± 16.69 | 54.06 ± 17.45 | 44.36 ± 16.42 | 39.18 ± 15.08 | 0 | |
Psychological health | ||||||
Intervention Group | 60. 06 ± 19.55 | 60.68 ± 19.59 | 64.83 ± 18.84 | 67.09 ± 18.22 | 15.07, (9.62–20.51) | 0.000 |
Control group | 63.36 ± 18.39 | 51.37 ± 17.93 | 40.86 ± 16.83 | 36.78 ± 15.42 | 0 | |
Social relationships | ||||||
Intervention Group | 63.35 ± 24.07 | 67.06 ± 21.40 | 71.62 ± 19.61 | 74.46 ± 18.43 | 24.79, (18.92–30.67) | 0.000 |
Control group | 57.76 ± 18.85 | 47.74 ± 18.70 | 37.83 ± 17.36 | 33.96 ± 16.39 | 0 | |
Environment | ||||||
Intervention Group | 66.85 ± 20.99 | 70.57 ± 19.27 | 73.95 ± 17.42 | 76.40 ± 16.20 | 21.07, (15.86–26.29) | 0.000 |
Control group | 64.95 ± 16.41 | 54.63 ± 16.76 | 44.66 ± 16.26 | 39.21 ± 15.17 | 0 | |
Total quality of life | ||||||
Intervention Group | 257.49 ± 80.00 | 268.55 ± 73.74 | 283.67 ± 67.92 | 294.11 ± 64.02 | 81.95, (62.11–101.80) | 0.000 |
Control group | 251.37 ± 60.79 | 207.80 ± 59.23 | 167.71 ± 56.85 | 149.12 ± 50.85 | 0 |
Change in the psychological effects (anxiety, depression)
Variables | Baseline | 1th follow-up | 2nd follow-up | 3rd follow-up | Effect of intervention | Statistics |
---|---|---|---|---|---|---|
Mean ± SD | Mean differences (95% CI) | |||||
Psychological effect Depression | ||||||
Intervention Group | 1.40 ± 1.06 | 0.77 ± 0.83 | 0.56 ± 0.88 | 0.61 ± 0.87 | −0.56, (−0.85–0.27) | 0.000 |
Control group | 1.28 ± 1.03 | 1.36 ± 1.00 | 1.43 ± 0.95 | 1.53 ± 1.00 | 0 | |
Anxiety | ||||||
Intervention Group | 2.14 ± 0.80 | 1.80 ± 0.92 | 1.22 ± 1.02 | 1.20 ± 0.94 | −0.31, (−0.59–0.03) | 0.028 |
Control group | 1.98 ± 0.93 | 1.90 ± 0.98 | 1.86 ± 1.00 | 1.88 ± 0.98 | 0 |